Related Experiment Video

Updated: Jun 21, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

[Growth of breast cancer cells is inhibited in vitro by cyclin E-siRNA]

Wen-shan He1, Tao Huang, Jing-hua Ren

  • 1Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|July 21, 2009
PubMed
Abstract

Insights

Inhibiting cyclin E in breast cancer cells halts cell cycle progression and reduces tumor growth. This approach enhances chemotherapy effectiveness, offering a potential new strategy for breast cancer treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Context:

  • Cyclin E plays a crucial role in cell cycle regulation.
  • Dysregulation of cyclin E is implicated in various cancers, including breast cancer.
  • Targeting cell cycle proteins is a key strategy in cancer therapy.

Purpose:

  • To investigate the effect of cyclin E inhibition on the biological characteristics of the MCF-7 breast cancer cell line.
  • To assess the impact of reduced cyclin E expression on cell proliferation, cell cycle progression, and chemosensitivity.
  • To evaluate the in vivo tumorigenic potential of breast cancer cells with inhibited cyclin E.

Summary:

  • Human breast cancer cell line MCF-7 was transfected with cyclin E siRNA to silence its expression.
  • RT-PCR and Western blot confirmed significant inhibition of cyclin E at both RNA and protein levels.
  • CCK-8 assays, flow cytometry (FCM), and in vivo studies in nude mice demonstrated reduced proliferation, G(1) cell cycle arrest, and decreased tumor formation.

Impact:

  • Inhibition of cyclin E effectively blocks breast cancer cell cycle progression at the G(1) phase.
  • Reduced cyclin E expression leads to decreased cell growth, differentiation, and proliferation.
  • Targeting cyclin E significantly increases breast cancer cell sensitivity to chemotherapy, suggesting therapeutic potential.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...